ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. (NASDAQ: ADRX) is trading at $14.20, about ₹1,339 at today's USD/INR rate, as of 13 Nov 2026, 4:00 PM ET, down 4.76% today. Indian residents can buy ADARx Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$13.70
Today's high
$15.21
52 week low
$12.50
52 week high
$23.21
ADRX opened at $14.96, closed previously at $14.91, and has traded between $12.50 and $23.21 over the past 52 weeks.
About
ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases. The company offers hepatic-targeted programs, including Agazisiran, a complement factor B (CFB) program that represents a pipeline-in-a-product opportunity, where a single therapeutic candidate has the potential to address multiple indications; Onvuzosiran, a clinical program for the prevention of HAE attacks; and ADX-626, a Factor XI (FXI) program for secondary stroke prevention with additional clinical potential for stroke prevention in atrial fibrillation. It also offers extrahepatic-targeted programs, such as ADX-077, an adipose-targeted obesity program designed to reduce body weight and fat while preserving lean mass; and ADX-199, a neuron-targeted program designed to selectively silence and degrade amyloid-ß precursor protein (APP) mRNA in neurons, which is genetically linked to Alzheimer’s disease. The company was incorporated in 2019 and is based in San Diego, California.
Key statistics
Avg. volume
649.78K
Market cap
$1.57B
P/E Ratio
-5.77
Price-to-sales ratio
233.88
Enterprise value
$1.40B
Free cash flow yield
17.79%
Debt-to-equity ratio
0.01
Return on equity
36.14%
ROIC
-18.45%
Beta
0.00
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$3.45M
Earnings per share
-$0.97
Free cash flow
$259.35M
Net profit margin
-1431.77%
Gross margin
-231.03%
EBITDA
-$86.04M
Revenue growth
0.00%
Similar securities
This is not an investment recommendation
How to buy ADARx Pharmaceuticals from India
Indian residents can buy ADARx Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers. Read the full guide: how to invest in ADARx Pharmaceuticals from India
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for ADARx Pharmaceuticals and place an order
Find ADARx Pharmaceuticals by name or by its ticker, ADRX, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. ADARx Pharmaceuticals trades 8:00 pm – 2:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your ADARx Pharmaceuticals position in USD and INR. ADARx Pharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Trading and taxes when buying ADARx Pharmaceuticals from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneADARx Pharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
FAQs
Can Indian residents buy ADARx Pharmaceuticals stock?
Yes. ADARx Pharmaceuticals (ADRX) has been listed on NASDAQ since 2026, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one ADARx Pharmaceuticals share cost in rupees?
One ADARx Pharmaceuticals share is $14.20 — about ₹1,339 at a USD/INR rate of 94.29 on 13 Nov 2026. Both the ADARx Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying ADARx Pharmaceuticals from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of ADARx Pharmaceuticals?
Yes. One ADARx Pharmaceuticals share is $14.20, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in ADARx Pharmaceuticals.
How are gains on ADARx Pharmaceuticals shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the ADARx Pharmaceuticals price. Paasa issues a capital-gains statement for your return.
Does ADARx Pharmaceuticals pay a dividend?
No. ADARx Pharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade ADARx Pharmaceuticals from India?
NASDAQ trades 8:00 pm – 2:30 am IST in Indian time, so the close lands after midnight. The window shifts to 7:00 pm – 1:30 am IST when the US is on daylight time. Orders can only execute during that window.
Is there estate or inheritance tax on ADARx Pharmaceuticals shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare ADARx Pharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your ADARx Pharmaceuticals holding, its cost and its closing value.
How do I sell ADARx Pharmaceuticals and bring the money back to India?
You sell during market hours (8:00 pm – 2:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.